.:: Welcome to iQueueOnline ::.

Activity Detail

	Emerging Prevention Strategies for Herpes Zoster and Postherpetic Neuralgia (PHN) This activity has expired. The accredited provider can no longer issue certificates for this activity.

Program Overview The content and opinions presented in this activity are not meant to serve as a guideline for patient management and do not necessarily reflect the views of The GMR Group or Merck & Co., Inc. Health care professionals are encouraged to critically appraise the information presented, and are advised to consult appropriate resources for clinical information surrounding disease management and FDA-approved labeling for information about any product or device discussed in this activity.

Target Audience This program is intended for physicians, pharmacists, and nurses that treat seniors.

Learning Objectives Describe the clinical manifestations of herpes zoster Evaluate the efficacy and limitations of current pharmacotherapies for the management of herpes zoster and PHN Recognize the relationship between aging and increasing incidence and severity of herpes zoster and PHN Evaluate the efficacy and benefit for reducing the incidence and severity of both herpes zoster and PHN through vaccination Assess the public health burden of herpes zoster and PHN in older adults

Faculty Eric G. Tangalos, MD, FACP, AGSF, CMD Professor of Medicine and Chair, Primary Care Internal Medicine Co-Director, Robert and Arlene Kogod Program on Aging Mayo Clinic College of Medicine Rochester, MN Myron J. Levin, MD Professor of Pediatrics and Medicine University of Colorado Health Sciences Center School of Medicine Denver, CO Lewrence D. Gelb, MD Associate Professor, Medicine Washington University School of Medicine Division of Infectious Diseases St. Louis, MO

Accreditation Statement MD: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The University of Texas Health Science Center at San Antonio Medical School (UTHSCSA) and The GMR Group-Health Insights. UTHSCSA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. RN: The GMR Group-Health Insights is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation and is provider approved by the California Board of Registered Nursing California Provider # CEP 12643. RX: The GMR Group-Health Insights is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Program Number: 404-000-06-005-H01.

Disclosure of Conflicts of Interest Eric Tangalos, MD has disclosed his affiliation as a consultant / advisor with Janssen, Forest, Amgen, Pfizer. He has no financial relationship with commercial interest to disclose. Lawrence Gelb, MD has disclosed his affiliation with Merck & Co. as a lecturer. He discloses a financial relationship within the past 12 months with Merck & Co. as part of their Speaker's Bureau. Myron Levin, MD has disclosed his affiliation with Merck & Co. as consultant/advisor and investigator. He discloses a financial relationship by receiving grants and research support with Merck & Co, and has a share in the patent for Zostavax use.

Disclosure of Unlabeled Use Dr. Tangalos does not intend to discuss off-label/unapproved uses of products or devices. Dr. Gelb discloses that he may or may not discuss off-label/unapproved uses of products or devices. Dr. Levin does not intend to discuss off-label/unapproved uses of products or devices.